Data / Drug companies / Major Pharmaceuticals
Major Pharmaceuticals: 611 products in the FDA NDC directory, labeler code 0904
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Major Pharmaceuticals (labeler code 0904) lists 611 products in the FDA National Drug Code Directory, covering 278 finished drugs by generic name. By type: 478 prescription drugs, 133 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 16, 2026.
The request: Watch Major Pharmaceuticals (FDA labeler code 0904): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0904
- Products in commercial distribution
- 611
- Packages
- 779
- Finished drugs by generic name
- 278
- Prescription products
- 478
- Over the counter products
- 133
- Controlled substance products
- Schedule II 12, Schedule III 7, Schedule IV 8, Schedule V 14
- Flagged as original packager
- 150 of 150 products that carry the flag
- Started marketing in the last 12 months
- 40
- Products with a marketing end date set
- 41
- Earliest marketing start
- December 1, 1978
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 504 | 82.5% |
| Over the counter monograph drugs | 102 | 16.7% |
| Authorized generics (NDA) | 2 | 0.3% |
| Other unapproved drugs | 2 | 0.3% |
| New drug applications (NDA) | 1 | 0.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 478 | 78.2% |
| Over the counter drugs | 133 | 21.8% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 193 | 31.6% |
| Tablet, film coated | 163 | 26.7% |
| Capsule | 78 | 12.8% |
| Solution | 29 | 4.7% |
| Tablet, film coated, extended release | 26 | 4.3% |
| Tablet, delayed release | 14 | 2.3% |
| Tablet, extended release | 13 | 2.1% |
| Capsule, extended release | 13 | 2.1% |
| Suspension | 13 | 2.1% |
| Tablet, chewable | 12 | 2% |
| Liquid | 11 | 1.8% |
| Capsule, liquid filled | 9 | 1.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Trazodone Hydrochloride | 0904-7976 | Tablet | Generic drugs (ANDA) | October 16, 2026 |
| Trazodone Hydrochloride | 0904-7964 | Tablet | Generic drugs (ANDA) | October 16, 2026 |
| Banophen | 0904-7672 | Capsule | Over the counter monograph drugs | October 15, 2026 |
| Pseudoephedrine HCl | 0904-7669 | Tablet, film coated | Over the counter monograph drugs | September 15, 2026 |
| Midodrine Hydrochloride | 0904-7642 | Tablet | Generic drugs (ANDA) | September 1, 2026 |
| Midodrine Hydrochloride | 0904-7641 | Tablet | Generic drugs (ANDA) | September 1, 2026 |
| Midodrine Hydrochloride | 0904-7640 | Tablet | Generic drugs (ANDA) | September 1, 2026 |
| Peg3350 | 0904-7534 | Powder, for solution | Generic drugs (ANDA) | August 28, 2026 |
| Trospium Chloride | 0904-7619 | Tablet, film coated | Generic drugs (ANDA) | August 27, 2026 |
| Lidocaine Hydrochloride | 0904-7644 | Solution | Generic drugs (ANDA) | August 21, 2026 |
| Povidone-Iodine | 0904-7639 | Solution | Over the counter monograph drugs | August 14, 2026 |
| Valproic acid | 0904-7621 | Solution | Generic drugs (ANDA) | August 3, 2026 |
| Valproic acid | 0904-7620 | Solution | Generic drugs (ANDA) | August 3, 2026 |
| Tolterodine Tartrate | 0904-7575 | Capsule, extended release | Generic drugs (ANDA) | June 24, 2026 |
| Tolterodine Tartrate | 0904-7574 | Capsule, extended release | Generic drugs (ANDA) | June 24, 2026 |
| Nebivolol | 0904-7500 | Tablet | Generic drugs (ANDA) | May 14, 2026 |
| Amiodarone Hydrochloride | 0904-7576 | Tablet | Generic drugs (ANDA) | May 12, 2026 |
| Gabapentin | 0904-7615 | Capsule | Generic drugs (ANDA) | April 27, 2026 |
| Gabapentin | 0904-7614 | Capsule | Generic drugs (ANDA) | April 27, 2026 |
| Gabapentin | 0904-7613 | Capsule | Generic drugs (ANDA) | April 27, 2026 |
| Nitrofurantoin (monohydrate/macrocrystals) | 0904-7571 | Capsule | Generic drugs (ANDA) | April 6, 2026 |
| Celecoxib | 0904-7551 | Capsule | Generic drugs (ANDA) | April 6, 2026 |
| Celecoxib | 0904-7550 | Capsule | Generic drugs (ANDA) | April 6, 2026 |
| Oxcarbazepine | 0904-7595 | Tablet, film coated | Generic drugs (ANDA) | April 3, 2026 |
| Oxcarbazepine | 0904-7594 | Tablet, film coated | Generic drugs (ANDA) | April 3, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.